Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group - Concepedia

Concepedia

Publication | Open Access

Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

DOI Full Paper Access

358

Citations

30

References

2008

Year

Peter Bader, Hermann Kreyenberg, Günter Henze, Cornelia Eckert, Miriam Reising, André Willasch, Andrea Barth, Arndt Borkhardt, Christina Peters, Rupert Handgretinger,

Journal of Clinical Oncology

Abstract

MRD is an important predictor for post-transplantation outcome. As a result, new strategies with modified stem-cell transplantation procedures will be evaluated in ALL-BFM trials.

References

	Year	Citations

Page 1